Literature DB >> 10490885

Decreased [Ca(2+)](i) during inhibition of coronary smooth muscle contraction by 17beta-estradiol, progesterone, and testosterone.

J G Murphy1, R A Khalil.   

Abstract

The clinical observation that coronary heart disease is more common in men and postmenopausal women than in premenopausal women has suggested cardiovascular protective effects of female sex hormones including hormone-mediated coronary vasodilation. We investigated whether the sex hormones induced coronary relaxation is due to a decrease in [Ca(2+)](i) as measured in single coronary smooth muscle cells isolated from gonadectomized male and female pigs. In the presence of external Ca(2+), prostaglandin F(2alpha) (PGF(2alpha); 10(-5) M) and membrane depolarization by 51 mM KCl caused significant cell contraction and maintained increase in [Ca(2+)](i) to 297 +/- 4 and 341 +/- 20 nM, respectively. At 10(-9) to 6 x 10(-7) M, 17beta-estradiol, progesterone, and testosterone caused inhibition of PGF(2alpha)- and KCl-induced contraction and [Ca(2+)](i) with 17beta-estradiol being most effective. 17alpha-Estradiol did not affect PGF(2alpha)-induced contraction, and the inhibition of PGF(2alpha) contraction by 17beta-estradiol, progesterone, or testosterone was abolished by tamoxifen and ICI 182, 780, RU-486, or flutamide, respectively. 17beta-Estradiol caused similar inhibition of PGF(2alpha)- and KCl-induced contraction and [Ca(2+)](i). Progesterone and testosterone caused greater inhibition of PGF(2alpha)-induced cell contraction and [Ca(2+)](i) compared with the KCl responses. In Ca(2+)-free (2 mM EGTA) solution, caffeine (10 mM) and carbachol (10(-5) M), which activate Ca(2+) release from intracellular stores, caused small cell contraction and transiently increased [Ca(2+)](i) to 256 +/- 53 and 262 +/- 32 nM, respectively. Sex hormones did not significantly affect caffeine- or carbachol-induced contraction or [Ca(2+)](i). Thus, 17beta-estradiol, progesterone, and testosterone cause relaxation of coronary smooth muscle cells and decrease [Ca(2+)](i) mainly by inhibiting Ca(2+) entry from extracellular space but not Ca(2+) release from intracellular stores. The differences in potency of sex hormones in reducing cell contraction and [Ca(2+)](i) suggest differences in the sensitivity of the PGF(2alpha)- and depolarization-activated Ca(2+) entry pathways to inhibition by sex hormones.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490885

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  41 in total

1.  Testosterone acts as a coronary vasodilator by a calcium antagonistic action.

Authors:  K M English; R D Jones; T H Jones; A H Morice; K S Channer
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 4.256

Review 2.  Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.

Authors:  V B Gencel; M M Benjamin; S N Bahou; R A Khalil
Journal:  Mini Rev Med Chem       Date:  2012-02       Impact factor: 3.862

Review 3.  The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action?

Authors:  Richard D Jones; Peter J Pugh; T Hugh Jones; Kevin S Channer
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

4.  Estrogen receptor-mediated enhancement of venous relaxation in female rat: implications in sex-related differences in varicose veins.

Authors:  Joseph D Raffetto; Xiaoying Qiao; Katie G Beauregard; Raouf A Khalil
Journal:  J Vasc Surg       Date:  2010-04       Impact factor: 4.268

Review 5.  Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.

Authors:  Durr-e-Nayab Masood; Emir C Roach; Katie G Beauregard; Raouf A Khalil
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

6.  Non-genomic effect of testosterone on airway smooth muscle.

Authors:  V Kouloumenta; A Hatziefthimiou; E Paraskeva; K Gourgoulianis; P A Molyvdas
Journal:  Br J Pharmacol       Date:  2006-10-30       Impact factor: 8.739

Review 7.  Testosterone and coronary vascular tone: implications in coronary artery disease.

Authors:  F L Wynne; R A Khalil
Journal:  J Endocrinol Invest       Date:  2003-02       Impact factor: 4.256

8.  Subtype-specific estrogen receptor-mediated vasodilator activity in the cephalic, thoracic, and abdominal vasculature of female rat.

Authors:  Ossama M Reslan; Zongzhi Yin; Graciliano R A do Nascimento; Raouf A Khalil
Journal:  J Cardiovasc Pharmacol       Date:  2013-07       Impact factor: 3.105

9.  Pregnancy-associated adaptations in [Ca2+]i-dependent and Ca2+ sensitization mechanisms of venous contraction: implications in pregnancy-related venous disorders.

Authors:  Yin Xia; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-03       Impact factor: 4.733

Review 10.  Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.

Authors:  Dia A Smiley; Raouf A Khalil
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.